Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan

Kobe Journal of Medical Sciences

Volumn 52, Issue 4, 2006, Pages 97-109

  Cai, Li ^a   Uchiyama, Hachiro ^a   Yanagisawa, Shinichiro ^b   Kamae, Isao ^a,b  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Cost effectiveness; Influenza; Pneumonia; Vaccine

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ELDERLY CARE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; JAPAN; MONTE CARLO METHOD; PNEUMONIA;

AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; MONTE CARLO METHOD; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES;

EID: 33748349463     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Allsup, S., Gosney, M., Haycox, A., Regan, M. 2003. Cost-benefit evaluation of routine influenza vaccination in people 65-74 years of age. Health Technol Assess. 7:1-65
2. Allsup, S., Gosney, M., Haycox, A., Regan, M. 2004. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomized controlled trial. Vaccine. 16:639-645
3. Barros, M.M., Cartagena, S.C., Bavestrello, F.L. 2005. Prevention of community-acquired pneumonia in adults. Revista Chilena de Infectologia. 22:67-74
4. Berg, G.D., Thomas, E., Silverstein, S., Neel, C.L., Mireles, M. 2004. Reducing medical service utilization by encouraging vaccines: randomized controlled trial. American Journal of Preventive Medicine. 27:284-288
5. Centers for Disease Control and prevention: 1998. Influenza and pneumococcal vaccination levels among adults ≥65 years. MMWR. 47:797-802
6. Chen YH, Liou SH, Chou CC, Su WL, Loh CH, Lin SH. 2004. Influenza and pneumococcal vaccination of the elderly in Taiwan. Vaccine. 22:2806-2811.
7. Christenson, P., Hedlund, B., Lundbergh, J., and Ortqvist, A. 2004. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 23:363-368.
8. Christenson, P., Lundbergh, J., Hedlund, B., and Ortqvist, A. 2001. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 357:1008-1011.
9. De Graeve D, Lombaert G, Goossens H. 2000 Cost-effectiveness analysis of pneumococcal vaccination of adults and elderly persons in Belgium. Pharmacoeconomics. 17:591-601.
10. Fedson, D.S., 1996. Evaluating the impact of influenza vaccination: A North American perspective. Pharmacoeconomics. 9:54-61
11. Fedson, D.S., 1997. Pneumococcal vaccination: four issues for western Europe. Biologicals. 25:215-219.
12. Fletcher, T.J., Tunnicliffe, W. S., Hammond, K., Roberts, K., Ayres, J.G. 1997. Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease. British Medical Journal. 314:1663.
13. Fukuda,Y., Yanagihara,K., Kawano,s. 2004. Haienn no Iryo Keizai. Geriat. Med. 42:587-592. [in Japanese] [Health economics of pneumonia (Title translation by the authors)]
14. Gross, P.A., Hermogenes, A.W., Sacks, H.S., Lau, J. La vandowski RA. 1995. The efficacy of Annals of Inter influenza vaccines in elderly persons: A meta-analysis and review of the literature. Intern Med. 123: 518-527.
15. Hedlund, J., Christenson, B., Lundbergh, P., Ortqvist, A. 2003. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up. Vaccine. 21:3906-3911.
16. Honkanen P.O., Keistinen, T., Kivela, S.L. 1996. Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly. Arch Intern Med. 156:205-208.
17. Infectious Disease Surveillance Center of Japan 2004. The Topic of This Month. 25:297 Web information: http://idsc.nih.go.jp/iasr/25/297/tpc297-j.html
18. Ishida T, Hashimoto T, Arita M, Ito I, Osaka M. 1998. Etiology of community-acquired pneumonia in hospitalized patients. A 3-year prospective study. Chest. 114:1588-1593
19. Jonkers, R.E., Boersma, W.G. 2003. Pneumococcal vaccination in adults. Ned Tijdschr Geneeskd. 147:437-441
20. Kashiwagi, S. 1998. Influenza among the elderly. Rinsho to Kenkyu. 75:74-75. [in Japanese]
21. Ministry of Health, Labour and Welfare 2002. Survey of medical care activities in public health insurance. Web information: http://wwwdbtk.mhlw.go. jp/toukei/data/650/2002/toukeihyou/0004469/t0093191/ji41_002.html
22. Ministry of Health, Labour and Welfare. 2002. Vital statistics of Japan. Web information: http://www1.mhlw.go.jp/toukei-i/toukeihp/9nenpo_8/deth2.html
23. Ministry of Health, Labour and Welfare. 2002. Patient survey. Web information: http://wwwdbtk.mhlw.go.jp/toukei/data/150/2002/toukeihyou/0004584/ t0094266/j48_001.html
24. Ministry of Health, Labour and Welfare. 2002. Monthly labor survey statistics. Web information: http://wwwdbtk.mhlw.go.jp/toukei/kouhyo/ indexkr_1_4.html
25. Ministry of Labor. 1999. Basic survey on wage structure. Web information: http://wwwdbtk.mhlw.go.jp/toukei/kouhyo/indexkr_4_5_1.html
26. Nichol, K.L. 1999. The additive benefit of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 17:91-93.
27. Nichol, K.L., Goodman, M. 2002. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine. 20:21-24
28. Okubo, I., Hoshi, S. 2002. 65-sai ijyo kourei sha e no Influenza yobou seshy no hiyou kouka bunnseki. [in Japanese]. [Cost-effectiveness analysis of influenza vaccination among the elderly over 65 years of age. (Title translation by the authors)] Web information: http://mhlw-grants.niph.go.jp/niph/search/ NIDD00.do
29. Postma MJ, Heijnen ML, Jager JC. 2001. Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands. Pharmacoeconomics. 19:215-222
30. Salo, H., Sintonen, H., Pekka, N.J., Linna, M., Nohynek, H., Verho, J., Kilpi, T. 2005. Economic evaluation of pneumococcal conjugate vaccinations in Finland. Scand J Infect Dis. 37:821-832
31. Shorr AF. 2005. Preventing pneumonia: the role for pneumococcal and influenza vaccines. Clin Chest Med. 26: 123-134.
32. Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, Plouffe JF, Cetron MS, Butler JC. 1997. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 278:1333-1339.
33. Socan, M., Frelih, T., Janet, E., Petras, T., Peternelj, B. 2004. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine. Vaccine. 22:3087-3091.
34. Statistical Survey Department, Statistics Bureau, Ministry of Public Management, Home Affairs, Posts and Telecommunications. 2003. Labour force participation rate. Labour force by age group and Labour force status. Web information: http://www.stat.go.jp/data/nenkan/zuhyou/y1602000.xls
35. Tateyama, M. 2002. Kourei sha haienn no tiryou sennryaku. Geriat Med. 40:1585-1591. [in Japanese] [Prevention and treatment of pneumonia among the elderly. (Title translation by the authors)]
36. Weaver M, Krieger J, Castorina J, Walls M, Ciske S. 2001. Cost-effectiveness of combined outreach for the pneumococcal and influenza vaccines. Arch Intern Med. 161:111-120.
37. While, A., George, C., Murgatroyd, B. 2005. Promoting influenza vaccination in older people: rationale and reality. Br J Community Nurs. 10:427-430